technologynetworks

NCBI Adopts Standard for Accepting 454's Sequencing Data

454 Life Sciences Corporation, a subsidiary of CuraGen Corporation has announced that the National Center for Biotechnology Information (NCBI) has added a standard submission format for its Trace ...
technologynetworks

Perlegen and 454 to Collaborate in Drug Response Sequencing Study

Perlegen Sciences, Inc., and 454 Life Sciences, part of Roche Diagnostics, announced a collaboration to conduct large scale genetic re-sequencing in hundreds of human DNA samples collected by Perlegen ...
Medscape

New Technology to Detect Low-level Drug-resistant HIV Variants

Genotypic testing is recommended as the preferred resistance testing method to guide therapy in antiretroviral-naive and antiretroviral-experienced persons. A major limitation of clinically available ...